​

​

Accepted Abstracts will be published in the American Heart Journal.

Editor-in-Chief: Daniel Mark, MD, MPH

​

ePosters are due May 26, 2023.

If an author wishes to make changes or withdraw their abstract, they must contact Alexes@tmioa.com no later than June 2, 2023. We accept ePosters in pdf format to be displayed on our virtual platform.

​

Abstract Submission Topics

Abstracts should address state-of-the-art clinical research aspects of diabetes and the heart. (As an example, obesity by itself will NOT qualify, but obesity as it relates to diabetes and/or cardiovascular disease will qualify). 

​

Topics include: diabetes, hypoglycemia, prediabetes, and/or cardiometabolic syndrome, retinopathy, obesity, neuropathy, dyslipidemia, triglycerides, cholesterol, hypertension, congestive heart failure (CHF), atherosclerosis, cardiovascular disease, arrhythmia, kidney/renal disease, cardiorenal syndrome, thrombosis, coagulation abnormalities, therapeutics, clinical trials, cardiovascular outcome trials, epidemiology, fatty liver, inflammation, guidelines on practice, technology, peripheral vascular disease, and related conditions. Although the posters are not designed for basic science, abstracts which consider unknown MOA (mode of action) of medications or pathophysiology of related medical conditions may be accepted.   

​

Abstract Poster Presentations

Abstracts may be submitted for poster presentation. If selected for poster presentation, the author(s) or presenter(s) are required to register for the Congress and to be present during the poster sessions. The presenter in attendance must be one of the authors listed on the abstract. Poster Presentation Session Time and Date TBA.

   ​ 

Abstract Oral Presentations

Four of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session - Time and Date TBA  (once ready, 7th HiD agenda may be viewed at heartindiabetes.com/agenda). In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by a 5 minute period of Q&A. If selected, an author is required to register to the meeting and to be prepared with a PowerPoint presentation. Oral presenters who have an interest or involvement in selling a technology, program, product, and/or service to healthcare professionals must submit an official disclosure document in order to be considered for and to present their work at the abstract oral session.   ​ 

 

Top Abstract Awards

Awards will be given to the highest ranking abstracts. The award levels are: Gold, Silver, Bronze and honorable mention.  

 

**Please note: If an author wishes to make changes or withdraw their abstract, they must contact our staff no later than May 22, 2023. HiD cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. Any requests should be submitted via e-mail to info@tmioa.com.

​

In addition:

• Scientific materials presented at the 7th Annual Heart in Diabetes (2023) must not have been published or presented prior to June 09, 2023, other than in abstract form.

• All abstracts must be submitted electronically and should be no more than 250 words (Titles, author(s) names, and affiliations are not included in the word count).

• Graphs or figures submitted must be in TIFF or JPG format.

• All materials must arrive on or before the abstract deadline noted above.

• Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.

• Authorship on multiple abstracts is permitted.

• All submitted content will be graded by the 2023 Heart in Diabetes Scientific Abstract Committee.

• Abstracts will be published in an issue of the American Heart Journal. Click on the images to see a sample of the recently published works.  

 

 

The Abstract Poster Reception at the Exhibit Hall starts on Friday, June 9, from 6:15 pm to 7:15 pm. Early Poster Set-up will be available on Thursday, June 8, 2023, from 11:00 am to 6:00 pm. Please have your posters placed on your designated board before the day of the conference, as the Exhibit Hall opens on Friday, June 9, 2023, at 7:00 am.

​

Late Breaking Abstract Submission Deadline: May 22, 2023

• Accepted Abstracts will be published in American Heart Journal, Editor-in-Chief: Daniel Mark, MD, MPH

• Accepted Abstracts will have poster presentation at the meeting.

• Top Abstracts will be selected for oral presentation at the meeting.

• Top 4 Abstracts will receive awards and cash prizes.

Upon being accepted, deadline for abstract e-posters submissions is May 26, 2023. 

​

The Abstract Oral Presentation is on Saturday, June 10, 2023, starting at 8:00 pm to 9:00 pm.

 

The Oral Abstract Winner Award Presentation is on Sunday, June 11, 2023, at 8:00 am.

​

Important Notice: "Make sure you include in all abstracts involving human or animal studies state approval by ethics committees as well as authors’ affiliation in detail and country of origin."

​

​

​

​

​